Skip to content

Phenelzine

Monoamine Oxidase Inhibitor — NERVOUS SYSTEM

Also known as: 1-hydrazino-2-phenylethane, 2-phenylethylhydrazine, phenalzine, phenelzine sulfate, phenethylhydrazine

OfpFDA approvedATC N06AF03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Phenelzine is an ofp drug in the Monoamine Oxidase Inhibitor class catalogued in DrugCentral. It was first approved by the FDA in 1961. Its mechanism of action is classified as Monoamine Oxidase Inhibitors. DrugCentral lists 14 molecular targets, including MAOB, AOC3 and Maoa. Recorded indications include Depressive disorder.

  • Approval status: ofp (first approved 1961 by the FDA).
  • Drug class: Monoamine Oxidase Inhibitor.
  • Mechanism of action: Monoamine Oxidase Inhibitors.
  • Molecular targets: MAOB, AOC3, Maoa and Maob (14 listed in DrugCentral).
  • Indications: Depressive disorder.
  • ATC code: N06AF03 (Monoamine oxidase inhibitors, non-selective).
  • Molecular formula: C8H12N2; molecular weight 136.20 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Depressive disorder

Off-label uses (1)

  • Bulimia nervosa

Contraindications (28)

  • Alcoholism
  • Angina pectoris
  • Anxiety
  • Bipolar disorder
  • Cerebrovascular disease
  • Chronic heart failure
  • Conduction disorder of the heart
  • Diabetes mellitus
  • Disease of liver
  • Disorder of cardiovascular system
  • Disorder of coronary artery
  • Feeling agitated
  • Frequent Headache Disorder
  • Hypertensive disorder
  • Hypertensive Emergencies
  • Hyperthyroidism
  • Hypoglycemic disorder
  • Kidney disease
  • Liver function tests abnormal
  • Low blood pressure
  • Myelogram
  • Orthostatic hypotension
  • Pheochromocytoma
  • Schizophrenia
  • Seizure disorder
  • Severe Headache Disorder
  • Suicidal thoughts
  • Syncope

Mechanism & targets

Mechanism of action (MoA)Monoamine Oxidase Inhibitors
Established pharmacologic classMonoamine Oxidase Inhibitor

Molecular targets (14)

TargetGeneActionActivity
Amine oxidase [flavin-containing] BMAOBinhibitorKi 7.82
Membrane primary amine oxidaseAOC3unknownIC50 7.70
Amine oxidase [flavin-containing] AMaoaunknownIC50 7.52
Amine oxidase [flavin-containing] BMaobunknownIC50 7.12
Amine oxidase [flavin-containing] AMAOAinhibitorIC50 6.84
Cytochrome P450 2C19CYP2C19unknownIC50 6.10
Cytochrome P450 2D6CYP2D6unknownIC50 6.00
Cytochrome P450 3A4CYP3A4unknownIC50 5.70
Cytochrome P450 2C9CYP2C9unknownIC50 5.40
Cytochrome P450 2C8CYP2C8inhibitorKi 5.14
FAD-linked sulfhydryl oxidase ALRGFERunknownAC50 5.12
Sodium-dependent dopamine transporterSLC6A3unknownKi 5.08
Indoleamine 2,3-dioxygenase 1IDO1unknownIC50 4.85
Lysine-specific histone demethylase 1AKDM1AunknownKi 4.75

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1961-06-09FDA—PARKE DAVIS

ATC classification

ATC codeTherapeutic hierarchy
N06AF03NERVOUS SYSTEM › PSYCHOANALEPTICS › ANTIDEPRESSANTS › Monoamine oxidase inhibitors, non-selective

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Serotonin syndrome176.2
Drug interaction121.0
Product complaint66.2
Drug ineffective48.3
Hypertensive crisis47.6
Food interaction46.8
Orthostatic hypotension37.4
Suicidal ideation33.8
Segmented hyalinising vasculitis33.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Phenelzine is on its molecule page.

Molecular formulaC8H12N2
Molecular weight136.20 g/mol
CAS number51-71-8
InChIKeyRMUCZJUITONUFY-UHFFFAOYSA-N
PubChem CID3675
NNCCC1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Phenelzine used for?

DrugCentral lists the following indications for Phenelzine: Depressive disorder.

How does Phenelzine work?

Phenelzine is classified as Monoamine Oxidase Inhibitors; its molecular targets in DrugCentral include MAOB (inhibitor), AOC3, Maoa and Maob.

When was Phenelzine first approved?

Phenelzine was first approved by the FDA in 1961.

What drug class does Phenelzine belong to?

Phenelzine is in the Monoamine Oxidase Inhibitor class.

What is the chemical formula of Phenelzine?

Phenelzine has the molecular formula C8H12N2 and a molecular weight of 136.20 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1961-06-09
AgencyFDA
Targets14
Indications1
FormulaC8H12N2
DrugCentral ID2123
Interactive profile